BIO President & CEO John F. Crowley released the following statement: “A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic ...

BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities. "Manufacturers should have the choice to effectuate ...

In accordance with its Bylaws and Articles of Incorporation, the Biotechnology Innovation Organization (BIO) is governed by its Board of Directors. The Full BIO Board of Directors is comprised of all ...

This is the only conference focused specifically on intellectual property in biotechnology, featuring the latest insights from biotech IP experts, as well as networking events designed to promote ...

BIO is in search of dynamic, professional candidates possessing the expertise and education outlined in the job titles listed below. If you are interested in working at BIO, please visit our current ...

Today, we explore BIO’s recommendations for how CMS can safeguard patient access under Medicare Part D, along with insights on a California Supreme Court case that could affect the complex drug ...

BIO Business Solutions ® is the largest cost savings program for the life sciences industry, operated by the Biotechnology Innovation Organization (BIO). BIO Business Solutions aggregates the ...

47 state and regional biotechnology associations partner with BIO to endorse BIO Business Solutions ® and offer their members discounted products and services. You do not have to be a BIO member to ...

Before a therapy is approved for delivery to patients a lot of hard work and research goes into demonstrating that the therapy is safe, effective, and high quality. We work to promote a regulatory ...

As the largest global non-profit biotechnology trade association representing startups to Fortune 500 companies, BIO is proud to host a portfolio of partnering conferences that not only unite and ...

Biotechnology is bringing us climate-smart technologies to recycle carbon, reduce greenhouse gas emissions and strengthen the resilience of agriculture and food production. Explore the resources and ...

Nanoligent is a preclinical stage drug discovery company based in Barcelona. We are focused on METASTASIS as an unmet clinical need, developing precision medicines that selectively kill metastatic ...